Alzheimer's disease progression slowed by new drug | Alzheimer's
Study shows cognition in early-stage patients on lecanemab declines by 27% less than those on placebo
Source: theguardian.com
Stay updated with breaking news from Prof Jon Schott. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Study shows cognition in early-stage patients on lecanemab declines by 27% less than those on placebo